YOUR BEAUTY HAS A FUTURE · 2019-12-19 · 4 TEOSYAL RHA® FILLERS DYNAMIC AESTHETICS TEOSYAL RHA®...
Transcript of YOUR BEAUTY HAS A FUTURE · 2019-12-19 · 4 TEOSYAL RHA® FILLERS DYNAMIC AESTHETICS TEOSYAL RHA®...
1
YOUR BEAUTY HAS A FUTURE
2
YOUR BEAUTY IS UNIQUE, AS IS OUR PORTFOLIO OF HA* FILLERS
Hyaluronic Acid is a natural component found in the skin. HA retains waters like a sponge, helping to keep the skin soft and firm. When used in aesthetic medicine, hyaluronic acid comes in the form of a gel1.
Your medical practitioner uses specific Hyaluronic Acids fillers to obtain a global lifting effect such as restoring lost volume in the mid-face, projecting the chin, correcting expression lines and under eye circles, plumping and redefining the lips, and finally enhancing skin texture.
The result needs to be natural, undetectable, and specifically tailored to your face and personality.
*Hyaluronic Acid
BEAUTIFUL FROM THE INSIDE OUT
3
RESPECTING FACIAL DYNAMICS IS THE KEY TO A BEAUTIFUL RESULT
A VISIBLE, YOUTHFUL RESULT THANKS TO
OPTIMAL PRODUCT INTEGRATION
Did you know that our face has 43 muscles that can create over 3000 expressions?2, 3 Our muscles, tissue and skin are constantly active, even when we sleep. But over the years our face loses its elasticity and volume leading to the appearance of wrinkles, sagging, and altered skin quality4.
To naturally integrate into facialstructures, a HA filler has to be able toresist pressure and seamlessly followfacial movements4-7.
1. Papakonstantinou et al. Hyaluronic acid: A key molecule in skin aging. Dermatoendocrinol. 2012; 4(3): 253-8. 2. De Paula M. et al. 2006 Psychology of Emotion. 3. D. Matsumoto D. et al. 2012 Nonverbal Communication: Science and Applications. 4. Michaud T, et al. Facial dynamics and emotional expressions in facial aging treatments. Journal of Cosmetic Dermatology. 2014; 0:1-13. 5. Gold MH, et al. Use of hyaluronic acid fillers for the treatment of the aging face. Clinical Interventions in Aging. 2007; 2(3):369–376. 6. Breithaupt AD, et al. Next-generation dermal fillers and volumizers. Cosmet Dermatol. 2012; 25:184-19. 7. Pierre S, et al. Basics of dermal filler rheology. Dermatol Surg. 2015; 41(suppl 1):120-6.
4
TEOSYAL RHA® FILLERS DYNAMIC AESTHETICS
TEOSYAL RHA® is the first* Hyaluronic Acid filler specifically designed to respect facial dynamics, with a unique and innovative technology developed to mimic the natural hyaluronic acid within our skin.This technology is designed to allow our gels to work in synchronisation with your facial expressions and provide a natural looking result, whilst remaining undetectable8.Your face is alive, TEOSYAL RHA® dermal fillers follow the movement!
YOUR FACE IS ALIVE
*at TEOXANE Laboratories
5
KEY FEATURES OFTEOSYAL RHA® FILLERS
STRENGTHCapacity of the gel to resist external and internal pressures
STRETCHAptitude of the gel to deform, morph, stretch, and rebound to its initial shape
OPTIMAL INTEGRATIONAbility to follow facial movements and seamlessly integrate into the skin
They are called RHA, Resilient Hyaluronic Acid, for their unique ability to accommodate to facial movements, rebound and resist the wear and tear of a lively face8.
TEOSYAL RHA®
IS A UNIQUE HA* RANGE DESIGNED
WITH AN INTEGRATED SHAPE MEMORY
*Hyaluronic Acid
8. Study report 1820. TEOSYAL® RHA keeps its mechanical properties on a large range of stress - Rheological properties of the RHA dermal fillers range. Data on file.
6
WHAT TYPE OF HA TREATMENTSFOR WHAT TYPE OF NEEDS?
Your practitioner will work to enhance your natural beauty and create a moreyouthful and harmonious appearancewhilst allowing you to express your emotions.
The procedure might usually begin by treating the deeper structures of the faceworking progressively towards the outer layers of the skin with the relevant gels.
Reshape the structure of the face (bone and fat pads) Correct wrinkles & folds Improve skin hydration & radiance
Some fillers contain an anaesthetic tomake the procedure more comfortable.
LOOK ON THE OUTSIDE
WHAT YOU FEEL LIKE INSIDE
2
3
1
7
FACIAL FEATURES
MODIFICATIONS
MODERATE TO SEVERE WRINKLES AND FOLDS
Volume loss in cheeks and
cheekbones
Sagging jawline
Hollowed temples
Retracted chin
Nasolabial folds
Severe wrinklesin the cheeks
Forehead lines
SOLUTIONDeep subdermal injections with a volumizing gel strong enough to resist continuous pressure and compression caused by repeated muscle movements, whilst correcting bone loss and/or shrunken fat pads.
SOLUTIONDermal or subdermal injections with a gel which fills the mobile areas of the face, thanks to its shape-memory qualities.
8
Crow’s feet
Accordion lines (Smiling lines)
Superficial wrinkles
Necklines
FACE Dehydrated tired skin and dull complexion
DÉCOLLETÉ Wrinkled, parched, dehydrated, paper-thin skin
FINE LINES& WRINKLES
SKINQUALITY
SOLUTIONA malleable gel with a light consistency should be injected superficially to fill wrinkles and plump the skin. This will erase any wrinkles and subtly fill hollowed areas of the face whilst rejuvenating the texture of the skin.
SOLUTIONYour skin needs revitalization and redensification while restoring its glow to its former youthful glory. A beauty booster gel with bioregenerators and antioxidants is required to treat the quality, density and brightness of the skin whilst also working on the texture to revitalise and restore a youthful glow.
9
EYE AND SMILE REGIONS TWO EXAMPLES OF SPECIFIC NEEDS
TEOSYAL® A COMPLETE PORTFOLIO OF GELS TO MEET EACH OF YOUR NEEDS*
EYE AREA SMILE AREA
SOLUTIONThis is the most fragile and delicate region to treat on our face. It is also where the first visible signs of aging occur. This area needs a light spreadable gel that fil ls the tear trough cavity with the objective of providing a natural-looking result9.
SOLUTIONTo reshape, plump and refresh lips with a natural look, a supple and resilient filler is needed. To smooth out barcode wrinkles, reshape and plump the lips, a light but highly malleable gel should be used.
Barcode
Oral commissures
Lip contour / Lip volume
Under eye / Tear trough
RHA® 1
ULTRA DEEP
RHA® 2
REDENSITY® 1 REDENSITY® 2 KISS®
RHA® 3 RHA® 4
9. Bass, L. Injectable filler techniques for facial rejuvenation, volumization, and augmentation. Facial Plast Surg Clin N Am. 2015; 23:479-488.
*Please refer to instruction for use.
10
TEOXANE COSMECEUTICALSA DYNAMIC SKINCARE REVOLUTION
Enhance your beauty and skin rejuvenation with TEOXANE’s cosmeceutical range of topical skincare.
Highly concentrated with a similar hyaluronic acid used in the filler range.The cosmeceutical products have beenformulated to strengthen, plump orprotect the skin while providing optimalhydration and glow.
ENHANCE YOUR BEAUTY
AND SKIN REJUVENATION
TEOXANE cosmetic range are cosmetic product according to European Regulation 1223/2009. Except Radiant Night Peel (medical device class 1). Cosmetic products are not designed to be injected.
11
The excellence of Swiss scienceEstablished in Geneva, Switzerland, in 2003, TEOXANE Laboratories spans across 90 countries worldwide. For over 15 years our ambition has been to satisfy the ever demanding aesthetic market with high performance, avant-garde products based on rigorous scientific research. We are dedicated to applying our industry leading expertise to designing and manufacturing hyaluronic acid dermal fillers and skincare products.
These high quality standards allowed TEOXANE to obtain the US FDA approval for 3 RHA® products in 2017.As a major player in aesthetic medicine and skincare, we offer effective solutions to aesthetic practitioners that allow them to help their clients enhance their natural beauty and feel their best at all times.
WHO WE ARETEOXANE LABORATORIES, GENEVA
12
A word from Madam Valérie TaupinIn today’s world, beauty is no longer a question of age. Women want their beauty to last into the future and to reflect their personalities. As a woman, I also share the same concerns. At TEOXANE Laboratories our focus has always been to be the global expert in the development of hyaluronic acids. Keeping innovation, quality and safety at the heart of everything we do!
Valérie TaupinCEO & Founder TEOXANE
I ’m not only the CEO
and founder of the company,
I ’m also a woman !
TEOXANE SALes Charmillles
Rue de Lyon, 105CH 1203 Geneva,
Switzerland
www.teoxane.com
* TEOSYAL RHA®, TEOSYAL® PureSense Redensity 1& 2, Ultra Deep and Kiss® are trademarks of the firm TEOXANE SA. These products are gels that contain hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend to not use lidocaine-containing products and please refer to products without lidocaine. Please consult your physician or pharmacist for more information. These products are class III medical devices and are regulated health products bearing the CE marking (CE0086) under this regulation. For professional use only. Please refer to instructions for use. The product availability depends on registration, please contact your local distributor. Please inform the manufacturer TEOXANE of any side effects or any claim as soon as possible to the following address: [email protected]. RHA® is a trademark of TEOXANE SA. RHA® 2, RHA® 3, RHA® 4 are products of TEOXANE SA. They are class III medical devices and have received FDA approval but are not yet commercialized in the United States. The United States Federal law restricts these devices to sale by or on the order of a physician or license practitioner. RHA® 2, RHA® 3 and RHA® 4 are indicated for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLF), in adults aged 22 years or older. RHA® 2, RHA® 3, and RHA® 4 are sterile gels containing crosslinked hyaluronic acid in physiological buffer and 0.3% lidocaine hydrochloride to reduce pain on injection. RHA® 2, RHA® 3 and RHA® 4 are contraindicated in patients with previous hypersensitivity to local anesthetics of the amide type, such as lidocaine.Please refer to the Instructions for Use (https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170002C.pdf). It is the practitioner’s full responsibility to read and inform the patient about contraindications, warnings, precautions, risks and benefits.
5004
39/0
0 -
Janu
ary
201
9